NEKTAR THERAPEUTICS — Director's Dealing 2017

Feb 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2017-02-10

Reporting Person: Nicholson John (SVP & Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-10	Common Stock	M	45000	$4.65	Acquired	185326	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-10	Employee Stock Option (right to buy)	$4.65	M	45000	Disposed	2017-02-22	Common Stock (45000)	Direct

Footnotes

F1: This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised.